Listen: Lilly’s obesity drug, the power of radiation, & a biotech implosion
This week on "The Readout LOUD" podcast: What's a radiopharmaceutical? What does it mean to be Zepbound? And who's to blame for a biotech blow-up?
What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them. We also discuss the approval of Eli Lilly’s curiously named treatment for obesity, the latest implosion for a promising biotech company, and some news in the world of shareholder activism.
What's Your Reaction?
